(-)-Lirioresinol A

(-)-Lirioresinol A - Names and Identifiers

Name	(3aα,6aα)-1α,4α-Bis(3,5-dimethoxy-4-hydroxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan
Synonyms	(-)-Lirioresinol A (-)-EPISYRINGARESINOL (3aα,6aα)-1α,4α-Bis(3,5-dimethoxy-4-hydroxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan 1α,4α-Bis(3,5-dimethoxy-4-hydroxyphenyl)-3aα,4,6,6aα-tetrahydro-1H,3H-furo[3,4-c]furan (3R,3aβ,6aβ)-3β,6β-Bis(3,5-dimethoxy-4-hydroxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan Phenol, 4,4'-[(1R,3aS,4S,6aS)-tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl]bis[2,6-dimethoxy-
CAS	6216-82-6

(-)-Lirioresinol A - Physico-chemical Properties

Molecular Formula	C22H26O8
Molar Mass	418.44
Storage Condition	2-8℃

(-)-Lirioresinol A - Introduction

(3a α,6a α)-1α,4α-Bis(3, 4α-Bis) tetrahydro-1H,3H-furo[3,4-c]furan is an organic compound with the following properties:

1. Appearance: White or off-white crystalline solid.
2. Molecular formula: C24H26O9.
3. Molecular weight: 458.46g/mol.
4. Melting Point: about 145-150 ℃.
5. Solubility: Soluble in most common organic solvents, such as chloroform, dimethylformamide and ethanol.

The main use of this compound is in the field of medicine. It has antibacterial, antiviral and antitumor biological activity. Therefore, it can be used as a synthetic intermediate or pharmaceutical ingredient for drug development.

The method for preparing (3a α 6a α)-1α,4α-Bis(3, 4α-Bis) tetrahydro-1H,3H-furo[3,4-c]furan is relatively complicated. One common synthetic approach is to perform tandem reactions, including nucleophilic substitution reactions and ring-closing reactions, through the corresponding starting materials. The specific preparation method may need further research and experimental verification.

With regard to safety information, current research and literature are insufficient to provide detailed safety information due to the specific properties and applications of this compound. When performing laboratory operations or other related applications, the relevant chemical handling and safety operation guidelines should be strictly followed, and risk assessment and management should be carried out on a case-by-case basis. During use, inhalation, ingestion and contact with skin or eyes must be avoided. If an accident occurs, seek medical attention immediately and bring information about the compound.

Last Update：2024-04-09 21:54:55